Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantation

Authors

David W. Reid
E Haydn Walters, University of Notre Dame AustraliaFollow
David P. Johns
C Ward
Graham P. Burns
Pam Liakakos
Trevor J. Williams
Greg I. Snell

Publication Details

Reid, D. W., Walters, E. H., Johns, D. P., Ward, C., Burns, G. P., Liakakos, P., et al. (2005). Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantation. Journal of Heart and Lung Transplantation, 24(4), 489-492. doi:10.1016/j.healun.2004.02.006

Abstract

Because bronchial hyperresponsiveness has been linked to the bronchiolitis obliterans syndrome (BOS), we determined PD₂₀ methacholine (PD_20(M)), PD₁₅ hypertonic saline (PD_15(HS)) and their dose-response slopes (DRS_M and DRS_HS) in 8 single and 18 double lung transplant recipients within 1 year of lung transplantation and examined the relationship to bronchoalveolar lavage cell profiles and subsequent development of BOS. Twenty-two patients (81%) had a positive methacholine and 6 (25%) a positive hypertonic saline challenge. A positive PD_15(HS) was associated with an increased risk for BOS at 2 years (odds ratio 12.6, 95% confidence interval 1.3–123.5, p < 0.05), and time to BOS was significantly and negatively related to DRS_HS (r = −0.5, p < 0.05) — that is, the greater the response, the shorter the time to BOS. Interestingly, DRSHS correlated positively with recipient:donor total lung capacity ratio (r = 0.5, p < 0.05), but there was no relationship between either challenge result and airway inflammation. Methacholine hyperresponsiveness is common after lung transplantation but is not prognostic, whereas response to hypertonic saline may reflect recipient:donor size matching and provide useful information regarding the potential for BOS development.

Keywords

peer-reviewed